James Hamilton
Chief of Discovery and Translational Medicine
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief of Discovery and Translational Medicine | $567,937 | $3,487,444 |
| 2023 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief of Discovery and Translational Medicine | $511,178 | $3,046,943 |
| 2022 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief of Discovery and Translational Medicine | $450,436 | $4,323,314 |
| 2021 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief of Discovery and Translational Medicine | $426,109 | $4,509,947 |
| 2020 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Chief of Discovery and Translational Medicine | $376,362 | $3,412,877 |
Earnings-call appearances
-
Arrowhead Pharmaceuticals, Inc. Q3 FY2026 Earnings Call2026-08-04
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
2026 Jefferies Global Healthcare Conference2026-06-03
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-02-05
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-08-07
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-05-12
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-02-06
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2023-11-29
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-08-07
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Burford Capital Ltd Q1 FY2023 Earnings Call2023-05-16
Burford Capital Ltd (BUR)
-
Burford Capital Ltd Q4 FY2022 Earnings Call2022-12-31
Burford Capital Ltd (BUR)
-
Arrowhead Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2022-12-31
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Burford Capital Ltd Q2 FY2022 Earnings Call2022-06-30
Burford Capital Ltd (BUR)
-
Arrowhead Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-05-10
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-02-02
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Burford Capital Ltd Q4 FY2021 Earnings Call2021-12-31
Burford Capital Ltd (BUR)
-
Arrowhead Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2021-11-22
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Arrowhead Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-02-04
Arrowhead Pharmaceuticals, Inc. (ARWR)
-
Burford Capital Ltd Q4 FY2020 Earnings Call2020-12-31
Burford Capital Ltd (BUR)
-
Burford Capital Ltd Q2 FY2020 Earnings Call2020-06-30
Burford Capital Ltd (BUR)